Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer. The SELEnium and BLAdder cancer Trial (SELEBLAT)

Rights and permissions This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Arch Public Health 73, P5 (2015). https://doi.org/10.1186/2049-3258-73-S1-P5 Download citation * Published: 17 September 2015 * DOI: https://doi.org/10.1186/2049-3258-73-S1-P5 Keywords * Selenium * Bladder Cancer * Standard Care * Transitional Cell Carcinoma * Selenium Concentration Comments By submitting a comment you agree to abide by our Terms and Community Guidelines. P5 (2015) Cite this article [RAW_REF_TEXT] 769 Accesses [/RAW_REF_TEXT] [RAW_REF_TEXT] 1 Citations [/RAW_REF_TEXT] [RAW_REF_TEXT] Metrics details [/RAW_REF_TEXT] Poster presentation Open Access Published:17 September 2015 [/RAW_REF_TEXT] Phase III randomised chemoprevention study of Selenium on the recurrence of non-invasive bladder cancer.